CTIM-03. PHASE II STUDY OF REGORAFENIB IN BEVACIZUMAB REFRACTORY RECURRENT GLIOBLASTOMA

Yasmeen Rauf; Cathy Schilero; David Peereboom; Manmeet Ahluwalia

doi:10.1093/NEUONC/NOAA215.137

CTIM-03. PHASE II STUDY OF REGORAFENIB IN BEVACIZUMAB REFRACTORY RECURRENT GLIOBLASTOMA

Yasmeen Rauf, Cathy Schilero, David Peereboom, Manmeet Ahluwalia

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1093/NEUONC/NOAA215.137
State	Published - Nov 9 2020
Event	Neuro-oncology - Duration: Nov 9 2020 → …

Conference

Conference	Neuro-oncology
Period	11/9/20 → …

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1093/NEUONC/NOAA215.137License: Unspecified

Cite this

@conference{8a55976e48b244ff898dee63add79b8d,

title = "CTIM-03. PHASE II STUDY OF REGORAFENIB IN BEVACIZUMAB REFRACTORY RECURRENT GLIOBLASTOMA",

author = "Yasmeen Rauf and Cathy Schilero and David Peereboom and Manmeet Ahluwalia",

note = "AbstractBACKGROUND. Most patients with glioblastoma (GBM) receive bevacizumab as part of their treatment. There is no good therapeutic option after bevacizumab; Neuro-oncology ; Conference date: 09-11-2020",

year = "2020",

month = nov,

day = "9",

doi = "10.1093/NEUONC/NOAA215.137",

language = "American English",

}

TY - CONF

T1 - CTIM-03. PHASE II STUDY OF REGORAFENIB IN BEVACIZUMAB REFRACTORY RECURRENT GLIOBLASTOMA

AU - Rauf, Yasmeen

AU - Schilero, Cathy

AU - Peereboom, David

AU - Ahluwalia, Manmeet

N1 - AbstractBACKGROUND. Most patients with glioblastoma (GBM) receive bevacizumab as part of their treatment. There is no good therapeutic option after bevacizumab

PY - 2020/11/9

Y1 - 2020/11/9

UR - https://academic.oup.com/neuro-oncology/article/22/Supplement_2/ii33/5960613

U2 - 10.1093/NEUONC/NOAA215.137

DO - 10.1093/NEUONC/NOAA215.137

M3 - Presentation

T2 - Neuro-oncology

Y2 - 9 November 2020

ER -

CTIM-03. PHASE II STUDY OF REGORAFENIB IN BEVACIZUMAB REFRACTORY RECURRENT GLIOBLASTOMA

Conference

Disciplines

Access to Document

Other files and links

Cite this